These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9286612)

  • 21. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME; Hewlett GH; Pimputkar G
    Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of AMPA receptor modulators on hippocampal and cortical function.
    Black MD; Wotanis J; Schilp DE; Hanak SE; Sorensen SM; Wettstein JG
    Eur J Pharmacol; 2000 Apr; 394(1):85-90. PubMed ID: 10771038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
    Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of amphetamine, morphine and dizocilpine (MK-801) on spontaneous alternation in the 8-arm radial maze.
    Hölter SM; Tzschentke TM; Schmidt WJ
    Behav Brain Res; 1996 Nov; 81(1-2):53-9. PubMed ID: 8950001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats.
    Kusljic S; van den Buuse M; Gogos A
    J Integr Neurosci; 2022 Jan; 21(1):17. PubMed ID: 35164453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor effects of amphetamine in rats pretreated with either dizocilpine or phencyclidine.
    Pesić V; Janać B; Milanović D; Tomić M; Veskov R; Rakić L
    Behav Brain Res; 2003 Dec; 147(1-2):211-5. PubMed ID: 14659587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus.
    Al-Amin HA; Weinberger DR; Lipska BK
    Behav Pharmacol; 2000 Jun; 11(3-4):269-78. PubMed ID: 11103881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):21-6. PubMed ID: 1685784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study.
    Ossowska K; Pietraszek M; Wardas J
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):384-8. PubMed ID: 8878072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
    Ninan I; Kulkarni SK
    Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Startle and sensorimotor gating in rats lacking CCK-A receptors.
    Feifel D; Priebe K; Shilling PD
    Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid synaptic plasticity of glutamatergic synapses on dopamine neurons in the ventral tegmental area in response to acute amphetamine injection.
    Faleiro LJ; Jones S; Kauer JA
    Neuropsychopharmacology; 2004 Dec; 29(12):2115-25. PubMed ID: 15150533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice.
    Boerner T; Bygrave AM; Chen J; Fernando A; Jackson S; Barkus C; Sprengel R; Seeburg PH; Harrison PJ; Gilmour G; Bannerman DM; Sanderson DJ
    Eur J Neurosci; 2017 Apr; 45(7):912-921. PubMed ID: 28186680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats.
    Rung JP; Carlsson A; Markinhuhta KR; Carlsson ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):833-9. PubMed ID: 15913873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats.
    Cervo L; Samanin R
    Brain Res; 1996 Aug; 731(1-2):31-8. PubMed ID: 8883851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
    Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
    Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
    Dall'Igna OP; Hoffmann A; da Silva AL; Souza DO; Lara DR
    Neurodegener Dis; 2004; 1(1):38-43. PubMed ID: 16908972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased locomotor response to amphetamine, but not other psychostimulants, in adult mice submitted to a low-protein diet.
    Dietrich MO; Mantese CE; Dos Anjos GM; Rotta LN; Perry ML; Souza DO; Lara DR
    Physiol Behav; 2004 Oct; 83(1):129-33. PubMed ID: 15501499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.